Sumitomo Seika Chemicals (4008) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended December 31, 2024 rose 5.1% year-over-year to ¥112,662 million, with operating profit up 37.3% to ¥8,689 million and profit attributable to owners of the parent up 71.5% to ¥6,903 million.

• Basic earnings per share increased to ¥520.38, and return on equity (ROE) improved to 7.1%.

• The company revised its full-year forecast upward, expecting net sales of ¥149,000 million and profit attributable to owners of the parent of ¥8,500 million.

Financial highlights

• Ordinary profit for the nine months was ¥9,603 million, up 49.2% year-over-year.

• Comprehensive income reached ¥7,219 million, a 6.5% increase year-over-year.

• Total assets as of December 31, 2024 were ¥148,997 million, up ¥12,692 million from March 31, 2024.

• Net assets increased to ¥98,651 million, with an equity-to-asset ratio of 66.2%.

Outlook and guidance

• Full-year forecasts for FY2024 were revised upward: net sales expected at ¥149,000 million (+4.2% YoY), operating profit at ¥11,000 million (+15.4%), ordinary profit at ¥12,000 million (+17.1%), and profit attributable to owners of the parent at ¥8,500 million (+37.8%).

• Basic earnings per share forecasted at ¥642.51, with ROE projected at 8.7%.

• Forecasts assume a weaker yen and higher naphtha prices.